Bayer’s Supreme Court battle over Roundup reveals corporate immunity, regulatory capture, and the erosion of public health protections
Original framing: “What does Bayer's US Supreme Court case mean for the thousands of Roundup lawsuits? - Reuters” — Reuters (via Google News)
Over 12,000 peer-reviewed studies link glyphosate to non-Hodgkin lymphoma, endocrine disruption, and soil microbiome collapse. Regulatory agencies like the EPA have repeatedly dismissed these findings, citing industry-funded research as definitive. The scientific consensus is clear: glyphosate is a probable carcinogen, yet the burden of proof is shifted to victims, not corporations.
The Bayer v. Roundup case is not merely a legal dispute but a symptom of a global system where corporations operate with impunity, regulators are captured, and marginalized communities bear the costs of ‘progress.
’ The scientific consensus on glyphosate’s harms is clear, yet the U.S. regulatory apparatus—shaped by Monsanto’s lobbying—has delayed justice for decades, mirroring historical patterns like the tobacco industry’s deception. Indigenous and peasant resistance, from the Zapatistas to the Mapuche, offers a counter-narrative: agrochemical dependency is a form of ecological colonialism that must be dismantled. A systemic solution requires decoupling science from corporate influence, redirecting subsidies toward agroecology, and creating global liability mechanisms—while centering the voices of those most affected. The trickster’s irony lingers: a product named for purity that poisons the earth, sold by a corporation that claims to ‘feed the world.’ The path forward demands we expose this absurdity and act before the land—and the people—are irreparably damaged.